Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Tinea Pedis Age: Adult Condition: Dermatophytosis |
Dose: Cream or spray – Apply to affected area Frequency: twice daily Duration: until significant clinical improvement (no more than 4 weeks) |
|
Indication: Tinea Corporis & Cruris Age: Adult Condition: Dermatophytosis |
Dose: Cream or spray – Apply once daily Duration: 1 week (no more than 4 weeks) |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Age: Pediatric |
Dose: NO_HEADER – Not FDA approved for peds Note: Not FDA approved for peds |
Administration
- Clean and dry affected area
- Apply thin layer
Side Effect
- Burning
- Contact dermatitis
- Dryness
- Exfoliation
- Irritation
- Pruritus
- Rash
- Irritation
- Stinging
- Liver failure
- Stevens-Johnson syndrome
- neutropaenia
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
CYP450 2D6 metabolized drugs
|
Possible increase in levels
|
|
Rifampicin
|
Decreased terbinafine concentration
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
Active or Chronic Liver Disease
|
Risk of liver complications
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Store in a cool and dry place, below 30°C, protect from light.
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.